Self-Assessed Severity as a Determinant of Coronavirus Disease 2019 Symptom Specificity: A Longitudinal Cohort Study
Anna Bershteyn(New York University), Elizabeth R. Brown(Fred Hutch Cancer Center), Helen C. Stankiewicz Karita(University of Washington), Keith R. Jerome(University of Washington), Angela M. Dahl(University of Washington), Ruanne V. Barnabas(Harvard University), Crystal Zheng(Tulane University), Miriam K. Laufer(University of Maryland, Baltimore), Patricia Kissinger(Tulane University), Robert Pitts(Bellevue Hospital Center), Raphael J. Landovitz(APLA Health), Michael K. Paasche‐Orlow(Tufts Medical Center), Kathleen M. Neuzil(Center for Global Development), Anna Wald(University of Washington), Mark D. Schwartz(New York University), Mark H. Wener(University of Washington), Angelica C Kottkamp(New York University), Meagan E. Deming(University of Maryland, Baltimore), Alexander L. Greninger(University of Washington), Alfred Luk(Tulane University), Lorna E. Thorpe(New York State Department of State), Connie Celum(University of Washington), Helen Y. Chu(Seattle Pacific University), Tracy Qi Dong(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Risa M. Hoffman(University of California, Los Angeles)
Cited by 0
Related Papers
Antiretroviral Prophylaxis for HIV Prevention in Heterosexual Men and Women
|New England Journal of Medicine|2012|3.3k
Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates
|New England Journal of Medicine|2020|2.7k
Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19
|New England Journal of Medicine|2021|2.6k
Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults
|Nature|2020|1.6k